Matthew Harrison
Stock Analyst at Morgan Stanley
(3.34)
# 980
Out of 4,876 analysts
703
Total ratings
47.64%
Success rate
2.22%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $464 → $460 | $441.30 | +4.24% | 39 | Jun 20, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Equal-Weight | $113 → $40 | $17.11 | +133.78% | 37 | Jun 17, 2025 | |
| INSM Insmed | Maintains: Overweight | $90 → $102 | $99.49 | +2.52% | 17 | Jun 11, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $958 → $755 | $521.00 | +44.91% | 52 | Jun 2, 2025 | |
| GILD Gilead Sciences | Maintains: Overweight | $130 → $135 | $110.67 | +21.98% | 42 | Apr 25, 2025 | |
| AVIR Atea Pharmaceuticals | Maintains: Equal-Weight | $6.2 → $6 | $3.44 | +74.42% | 10 | Apr 11, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $157 → $152 | $126.08 | +20.56% | 52 | Apr 9, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $39 → $32 | $27.16 | +17.82% | 25 | Apr 9, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $82 → $80 | $34.63 | +131.01% | 11 | Mar 17, 2025 | |
| TNYA Tenaya Therapeutics | Maintains: Overweight | $15 → $5 | $0.61 | +720.21% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $41 → $33 | $14.10 | +134.04% | 12 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $149.99 | +18.67% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $32.84 | +70.52% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $35.32 | +55.72% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.48 | +102.70% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $4 → $6 | $1.44 | +316.67% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $13.20 | -16.67% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $1.18 | +577.97% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $510 | $560.14 | -8.95% | 24 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.28 | +207.02% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $112 | $55.17 | +103.01% | 21 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $17.59 | +93.29% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $20.50 | +56.10% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $2.42 | +685.12% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $13 | $7.95 | +63.52% | 4 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.73 | +37.65% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $19.96 | -49.90% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $7.10 | +12.68% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $28.01 | +57.09% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $2.81 | +362.63% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $8.94 | +794.85% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $5.61 | +969.52% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $106.72 | +102.40% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $2.71 | +84.50% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.92 | +160.42% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $182.31 | -0.17% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $3.70 | +143.24% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $56.19 | -28.81% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $277.13 | +1.76% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $322.83 | -34.95% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $24.19 | +114.96% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $152.41 | +13.51% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $61 → $57 | $9.15 | +522.95% | 9 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $36.52 | +228.59% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $14.09 | +950.39% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $79.10 | +3.67% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $46.35 | +42.39% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $2.38 | +1,538.66% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $35.87 | +28.24% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $9.86 | +254.97% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $775.45 | -64.54% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.28 | +733.33% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $8.39 | +638.97% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $16.60 | +3.92% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $50 | $0.77 | +6,381.72% | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $68.37 | +21.40% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $57 | $29.64 | +92.31% | 4 | Oct 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $33.16 | -69.84% | 4 | Sep 10, 2018 |
Vertex Pharmaceuticals
Jun 20, 2025
Maintains: Equal-Weight
Price Target: $464 → $460
Current: $441.30
Upside: +4.24%
Sarepta Therapeutics
Jun 17, 2025
Downgrades: Equal-Weight
Price Target: $113 → $40
Current: $17.11
Upside: +133.78%
Insmed
Jun 11, 2025
Maintains: Overweight
Price Target: $90 → $102
Current: $99.49
Upside: +2.52%
Regeneron Pharmaceuticals
Jun 2, 2025
Maintains: Overweight
Price Target: $958 → $755
Current: $521.00
Upside: +44.91%
Gilead Sciences
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $110.67
Upside: +21.98%
Atea Pharmaceuticals
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $3.44
Upside: +74.42%
Biogen
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $157 → $152
Current: $126.08
Upside: +20.56%
Moderna
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $39 → $32
Current: $27.16
Upside: +17.82%
Legend Biotech
Mar 17, 2025
Maintains: Overweight
Price Target: $82 → $80
Current: $34.63
Upside: +131.01%
Tenaya Therapeutics
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.61
Upside: +720.21%
Mar 7, 2025
Assumes: Overweight
Price Target: $41 → $33
Current: $14.10
Upside: +134.04%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $149.99
Upside: +18.67%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $32.84
Upside: +70.52%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $35.32
Upside: +55.72%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.48
Upside: +102.70%
Sep 16, 2024
Maintains: Overweight
Price Target: $4 → $6
Current: $1.44
Upside: +316.67%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $13.20
Upside: -16.67%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $1.18
Upside: +577.97%
May 28, 2024
Maintains: Overweight
Price Target: $515 → $510
Current: $560.14
Upside: -8.95%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.28
Upside: +207.02%
Apr 26, 2024
Maintains: Overweight
Price Target: $115 → $112
Current: $55.17
Upside: +103.01%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $17.59
Upside: +93.29%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $20.50
Upside: +56.10%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $2.42
Upside: +685.12%
Mar 27, 2023
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $7.95
Upside: +63.52%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.73
Upside: +37.65%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $19.96
Upside: -49.90%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $7.10
Upside: +12.68%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $28.01
Upside: +57.09%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $2.81
Upside: +362.63%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $8.94
Upside: +794.85%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $5.61
Upside: +969.52%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $106.72
Upside: +102.40%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.71
Upside: +84.50%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.92
Upside: +160.42%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $182.31
Upside: -0.17%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $3.70
Upside: +143.24%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $56.19
Upside: -28.81%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $277.13
Upside: +1.76%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $322.83
Upside: -34.95%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $24.19
Upside: +114.96%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $152.41
Upside: +13.51%
Mar 10, 2022
Maintains: Equal-Weight
Price Target: $61 → $57
Current: $9.15
Upside: +522.95%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $36.52
Upside: +228.59%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $14.09
Upside: +950.39%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $79.10
Upside: +3.67%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $46.35
Upside: +42.39%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $2.38
Upside: +1,538.66%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $35.87
Upside: +28.24%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $9.86
Upside: +254.97%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $775.45
Upside: -64.54%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.28
Upside: +733.33%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $8.39
Upside: +638.97%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $16.60
Upside: +3.92%
Aug 18, 2020
Downgrades: Equal-Weight
Price Target: $50
Current: $0.77
Upside: +6,381.72%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $68.37
Upside: +21.40%
Oct 11, 2018
Maintains: Overweight
Price Target: $59 → $57
Current: $29.64
Upside: +92.31%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $33.16
Upside: -69.84%